Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 26 | 2025 | 1772 | 2.500 |
Why?
|
| Cesarean Section | 7 | 2024 | 63 | 2.340 |
Why?
|
| Diabetes, Gestational | 3 | 2025 | 56 | 2.230 |
Why?
|
| Pregnancy Outcome | 6 | 2025 | 102 | 1.720 |
Why?
|
| Perineum | 3 | 2019 | 9 | 1.240 |
Why?
|
| Retrospective Studies | 15 | 2025 | 2544 | 1.230 |
Why?
|
| Lacerations | 2 | 2019 | 6 | 1.220 |
Why?
|
| Premature Birth | 4 | 2025 | 95 | 1.200 |
Why?
|
| Pregnancy Complications | 5 | 2025 | 140 | 1.140 |
Why?
|
| Placenta | 2 | 2017 | 117 | 0.980 |
Why?
|
| Infant, Newborn | 8 | 2025 | 972 | 0.970 |
Why?
|
| Labor, Induced | 2 | 2016 | 4 | 0.970 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2025 | 11 | 0.930 |
Why?
|
| Female | 29 | 2025 | 24698 | 0.930 |
Why?
|
| Hypertriglyceridemia | 1 | 2025 | 16 | 0.890 |
Why?
|
| Pancreatitis | 1 | 2025 | 21 | 0.890 |
Why?
|
| Fetal Growth Retardation | 1 | 2025 | 53 | 0.890 |
Why?
|
| Urinary Incontinence | 2 | 2014 | 15 | 0.860 |
Why?
|
| Inhibins | 1 | 2024 | 5 | 0.860 |
Why?
|
| Adult | 20 | 2025 | 13872 | 0.850 |
Why?
|
| Aneuploidy | 1 | 2024 | 24 | 0.850 |
Why?
|
| alpha-Fetoproteins | 1 | 2024 | 32 | 0.840 |
Why?
|
| Consensus | 1 | 2023 | 48 | 0.780 |
Why?
|
| Needs Assessment | 1 | 2024 | 178 | 0.770 |
Why?
|
| Labor Pain | 1 | 2022 | 2 | 0.760 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2022 | 3 | 0.760 |
Why?
|
| Humans | 30 | 2025 | 43102 | 0.710 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 15 | 0.700 |
Why?
|
| Body Mass Index | 4 | 2019 | 925 | 0.700 |
Why?
|
| Hawaii | 7 | 2025 | 2011 | 0.670 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2020 | 2 | 0.660 |
Why?
|
| Obstetrics | 1 | 2020 | 43 | 0.650 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 22 | 0.640 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2019 | 5 | 0.630 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 48 | 0.630 |
Why?
|
| Cohort Studies | 5 | 2025 | 1759 | 0.590 |
Why?
|
| Obstetric Labor Complications | 1 | 2019 | 9 | 0.590 |
Why?
|
| Anal Canal | 1 | 2019 | 32 | 0.580 |
Why?
|
| Patient Compliance | 1 | 2020 | 233 | 0.580 |
Why?
|
| Receptors, Peptide | 1 | 2017 | 24 | 0.520 |
Why?
|
| Fetal Development | 1 | 2017 | 34 | 0.520 |
Why?
|
| Episiotomy | 1 | 2016 | 4 | 0.500 |
Why?
|
| Birth Injuries | 1 | 2016 | 7 | 0.500 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 49 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 93 | 0.490 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 22 | 0.480 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 30 | 0.480 |
Why?
|
| Version, Fetal | 1 | 2015 | 3 | 0.460 |
Why?
|
| Breech Presentation | 1 | 2015 | 4 | 0.460 |
Why?
|
| Nerve Block | 1 | 2015 | 5 | 0.460 |
Why?
|
| Analgesia, Obstetrical | 1 | 2015 | 4 | 0.460 |
Why?
|
| Biomedical Research | 1 | 2020 | 502 | 0.450 |
Why?
|
| Insulin | 1 | 2017 | 258 | 0.450 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2025 | 19 | 0.450 |
Why?
|
| Incontinence Pads | 1 | 2014 | 3 | 0.440 |
Why?
|
| Fecal Incontinence | 1 | 2014 | 3 | 0.440 |
Why?
|
| Disposable Equipment | 1 | 2014 | 6 | 0.440 |
Why?
|
| Validation Studies as Topic | 1 | 2014 | 8 | 0.440 |
Why?
|
| Tocolysis | 1 | 2014 | 2 | 0.440 |
Why?
|
| Tocolytic Agents | 1 | 2014 | 4 | 0.440 |
Why?
|
| Nifedipine | 1 | 2014 | 10 | 0.440 |
Why?
|
| Tachycardia | 1 | 2014 | 11 | 0.440 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2015 | 54 | 0.440 |
Why?
|
| Patient Simulation | 1 | 2014 | 14 | 0.430 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2014 | 5 | 0.430 |
Why?
|
| Hypotension | 1 | 2014 | 24 | 0.430 |
Why?
|
| Abdomen | 1 | 2014 | 13 | 0.430 |
Why?
|
| Pressure | 1 | 2014 | 50 | 0.430 |
Why?
|
| Proteins | 1 | 2017 | 382 | 0.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.410 |
Why?
|
| Hysterectomy | 1 | 2013 | 38 | 0.410 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 179 | 0.400 |
Why?
|
| Health Policy | 1 | 2015 | 184 | 0.400 |
Why?
|
| Robotics | 1 | 2013 | 43 | 0.400 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2025 | 40 | 0.360 |
Why?
|
| Postpartum Hemorrhage | 2 | 2023 | 18 | 0.310 |
Why?
|
| Logistic Models | 2 | 2023 | 1009 | 0.300 |
Why?
|
| Prevalence | 2 | 2025 | 1612 | 0.270 |
Why?
|
| Young Adult | 5 | 2019 | 5080 | 0.240 |
Why?
|
| Niacin | 1 | 2025 | 23 | 0.220 |
Why?
|
| Fetal Viability | 1 | 2024 | 6 | 0.220 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2024 | 1 | 0.220 |
Why?
|
| Estriol | 1 | 2024 | 9 | 0.210 |
Why?
|
| Chorionic Gonadotropin | 1 | 2024 | 16 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 27 | 0.210 |
Why?
|
| Genetic Testing | 1 | 2024 | 91 | 0.200 |
Why?
|
| Counseling | 1 | 2024 | 138 | 0.200 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2023 | 6 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2024 | 452 | 0.190 |
Why?
|
| Focus Groups | 1 | 2024 | 423 | 0.180 |
Why?
|
| Double-Blind Method | 1 | 2022 | 317 | 0.180 |
Why?
|
| Pain Measurement | 1 | 2022 | 183 | 0.170 |
Why?
|
| Qualitative Research | 1 | 2024 | 574 | 0.170 |
Why?
|
| Australia | 1 | 2020 | 103 | 0.160 |
Why?
|
| Education, Nursing | 1 | 2020 | 20 | 0.160 |
Why?
|
| Gestational Age | 2 | 2024 | 200 | 0.160 |
Why?
|
| Obstetrical Forceps | 1 | 2019 | 3 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 252 | 0.160 |
Why?
|
| Genes | 1 | 2019 | 56 | 0.160 |
Why?
|
| United States | 3 | 2024 | 5205 | 0.150 |
Why?
|
| Prenatal Care | 1 | 2020 | 93 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 375 | 0.150 |
Why?
|
| Hospitalization | 2 | 2020 | 485 | 0.150 |
Why?
|
| Patient Selection | 1 | 2020 | 205 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 67 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 235 | 0.140 |
Why?
|
| Dilatation and Curettage | 1 | 2018 | 4 | 0.140 |
Why?
|
| Adolescent | 3 | 2022 | 6081 | 0.140 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 20 | 0.130 |
Why?
|
| Obesity | 2 | 2017 | 1151 | 0.130 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2017 | 25 | 0.130 |
Why?
|
| Fetal Blood | 1 | 2017 | 48 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3156 | 0.130 |
Why?
|
| Fetus | 1 | 2017 | 101 | 0.130 |
Why?
|
| Organ Size | 1 | 2017 | 170 | 0.130 |
Why?
|
| Cardiotocography | 1 | 2016 | 2 | 0.130 |
Why?
|
| Birth Weight | 1 | 2017 | 95 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 94 | 0.120 |
Why?
|
| Heart Rate, Fetal | 1 | 2016 | 12 | 0.120 |
Why?
|
| Echocardiography | 1 | 2017 | 167 | 0.120 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2016 | 7 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 183 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2018 | 263 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 734 | 0.120 |
Why?
|
| Anesthesia, Spinal | 1 | 2015 | 2 | 0.110 |
Why?
|
| Anesthesia, Epidural | 1 | 2015 | 3 | 0.110 |
Why?
|
| Amnion | 1 | 2015 | 16 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 2015 | 6 | 0.110 |
Why?
|
| Decision Trees | 1 | 2015 | 22 | 0.110 |
Why?
|
| Cost Savings | 1 | 2015 | 18 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2016 | 131 | 0.110 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 18 | 0.110 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 8 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2015 | 27 | 0.110 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2015 | 41 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 60 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 863 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 934 | 0.110 |
Why?
|
| Urodynamics | 1 | 2014 | 5 | 0.110 |
Why?
|
| Lifting | 1 | 2014 | 5 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2014 | 20 | 0.110 |
Why?
|
| Cough | 1 | 2014 | 20 | 0.110 |
Why?
|
| Posture | 1 | 2014 | 61 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 242 | 0.110 |
Why?
|
| Gene Expression | 1 | 2017 | 701 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2017 | 1600 | 0.100 |
Why?
|
| Genital Diseases, Female | 1 | 2013 | 38 | 0.100 |
Why?
|
| Movement | 1 | 2014 | 119 | 0.100 |
Why?
|
| Gynecology | 1 | 2013 | 35 | 0.100 |
Why?
|
| Sex Factors | 1 | 2017 | 1028 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2013 | 59 | 0.100 |
Why?
|
| Canada | 1 | 2013 | 163 | 0.100 |
Why?
|
| Heart Rate | 1 | 2014 | 266 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 749 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2013 | 146 | 0.090 |
Why?
|
| Physicians | 1 | 2013 | 188 | 0.090 |
Why?
|
| Age Factors | 1 | 2014 | 1154 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2014 | 666 | 0.080 |
Why?
|
| Middle Aged | 2 | 2014 | 12222 | 0.070 |
Why?
|
| Risk Factors | 1 | 2016 | 3994 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2853 | 0.070 |
Why?
|
| Male | 3 | 2024 | 23409 | 0.060 |
Why?
|
| Oximetry | 1 | 2005 | 11 | 0.060 |
Why?
|
| Live Birth | 1 | 2024 | 9 | 0.050 |
Why?
|
| Neonatology | 1 | 2024 | 7 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2005 | 51 | 0.050 |
Why?
|
| Resuscitation | 1 | 2024 | 22 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1285 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 64 | 0.050 |
Why?
|
| Oxygen | 1 | 2005 | 218 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2024 | 142 | 0.050 |
Why?
|
| Reference Values | 2 | 2017 | 211 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 8214 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2017 | 92 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1063 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1857 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2005 | 12 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2005 | 32 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1175 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1546 | 0.010 |
Why?
|
| Child | 1 | 2005 | 3443 | 0.010 |
Why?
|